Background {#Sec1}
==========

Influenza is a pervasive infectious disease that remains a leading public health challenge worldwide \[[@CR1], [@CR2]\]. It is estimated that 291,243--645,832 annual deaths are caused by influenza globally \[[@CR3]\]. It has become an increasingly important cause of morbidity and mortality, especially for vulnerable groups, such as pregnant women, the elderly and children, and people living with chronic disorders \[[@CR4], [@CR5]\]. Influenza is also associated with a significant economic burden attributable to the considerable direct and indirect healthcare costs at the individual, institutional and societal levels \[[@CR4]--[@CR6]\].

Thankfully, potent and safe vaccines are available to combat the seasonal burden associated with influenza infections, and their administration is centered on evidence-based recommendations that ensure the effective and safe use of influenza vaccines \[[@CR7]--[@CR9]\]. Studies have indicated that annual influenza vaccination reduces the mortality and morbidity of healthcare professionals (HCPs) and patients \[[@CR10], [@CR11]\]. However, regular adherence to the yearly schedule of influenza vaccination, widespread acceptance and regular uptake of influenza vaccines and good vaccination coverage have proved challenging, and a variety of factors underlie these phenomena \[[@CR12], [@CR13]\]. These factors include hesitancy and aversion to vaccines, concerns about vaccine safety, misinformation/unfounded rumors, poor perception and/or inadequate knowledge of the direct and indirect health benefits associated with vaccinations and poorly informed vaccine-related decision-making by patients and HCPs \[[@CR14]--[@CR16]\]. HCPs play an important role in immunization through their appropriate knowledge, positive attitude, and ample information \[[@CR17]\].

A major factor that is consistently associated with patients' acceptance and uptake of vaccinations, compliance with vaccination schedules and reduction of hesitancy/aversion is the attitude and use of vaccinations by HCPs \[[@CR17], [@CR18]\]. In addition, vaccinated HCPs also have a noticeable effect on patients' decision to immunize \[[@CR19]\].

It is well reported that HCPs who have an unfavorable attitude, aversion or hesitancy to vaccinations pass off these vaccination-unfriendly attitudes to patients and tend to recommend vaccinations less frequently \[[@CR20], [@CR21]\]. Furthermore, the level of vaccine hesitancy among HCPs has been consistently linked to hesitancy and aversion to vaccination among patients and/or the general population \[[@CR17], [@CR22]\]. In addition, the quality, content and delivery of vaccine-related counseling/educational information by HCPs has proven valuable in enhancing patients' acceptance of vaccinations, reducing hesitancy, boosting vaccination coverage and guiding informed vaccination-related decisions \[[@CR11], [@CR16]\]. This is because patients often trust and rely on HCPs for information related to vaccines and vaccine-preventable diseases, and the therapeutic and public health benefits associated with vaccination \[[@CR16], [@CR23]\]. It is therefore important to conduct regular appraisal of HCP's attitude toward, acceptance of and participation in immunization, as these have been established as accurate predictors of acceptance and vaccination rate among patients and/or the general population \[[@CR24]\]. This is particularly important for highly infectious seasonal vaccine-preventable diseases, such as influenza, especially in a setting such as Saudi Arabia, which hosts the yearly Hajj, which is the world's largest gathering, with approximately three million people \[[@CR25]\]. This is arguably the only event with the highest density of people from different parts of the globe in such close proximity, a factor that increases the risk of influenza transmission ab initio \[[@CR26]\]. Furthermore, Saudi Arabia carries a significant burden of chronic noncommunicable diseases, such as diabetes, hypertension and other cardiovascular diseases, and these are patient groups that have increased susceptibility to the transmission of influenza infection \[[@CR4], [@CR9], [@CR27]\]. In addition, the frequent interactions of HCPs with patients and the close proximity within which they deliver healthcare services, especially in an institutionalized care setting, make both parties highly susceptible to the transmission of an infectious disease such as influenza \[[@CR7], [@CR8]\]. Hence, the inherent peculiar local susceptibility factors in Saudi Arabia, which increase the risk of influenza infections and the critical roles played by HCPs in enhancing vaccinations by patients, warrant regular assessment of the attitude and acceptance of and participation in influenza vaccination by HCPs. In Saudi Arabia, the influenza vaccine is not mandatory; however, the Scientific Committee for Influenza and Pneumococcal Vaccination (SCIPV) guidelines, which were established by the Saudi Thoracic Society (STS), recommend that both the public and HCPs receive the vaccine every year, particularly during influenza season, because the composition of the vaccine is modified annually. Both the Saudi Ministry of Health (MOH) and STS recommend that all HCPs should receive the influenza vaccine annually \[[@CR9], [@CR28]\]. This study is likely to provide current and up-to-date insights that may prove useful in assessing the impact of the current interventions used to improve influenza vaccination coverage in Saudi Arabia. Several studies have reported hesitancy, inadequate knowledge and poor uptake of influenza vaccine among HCPs in several parts of the world, including Saudi Arabia \[[@CR29]--[@CR31]\]. A previous study conducted in Saudi Arabia found that the vaccination rate was 38% \[[@CR31]\]. However, our literature search showed no current data for the 2016 winter season in Saudi Arabia. Thus, we conducted a study to determine the attitudes, knowledge, acceptance of and participation in HCP influenza vaccination in the north and central regions of Saudi Arabia. Additionally, to assess the effect of the influenza vaccine campaign, following the recommendations of our previous study, we assessed the vaccination rate among HCPs in Saudi Arabia during the 2012--2013 influenza season \[[@CR31]\]. This study will be helpful for better planning and policies regarding influenza vaccination in Saudi Arabia.

Methods {#Sec2}
=======

Study tool and design {#Sec3}
---------------------

A cross-sectional study was conducted in 8 major government-run and private hospitals and their primary care centers at distinct locations in the cities of Riyadh and Hail in Saudi Arabia in October--November 2016. A validated questionnaire composed of 31 close-ended questions and 5 sections was used. The first section discussed questions related to the demographics of participants. In the second section, there were questions about their attitude toward vaccination, such as if they routinely get vaccinated and the reason why they do not get vaccinated. Based on their answers, the participants were stratified into two groups (i.e., vaccinated and unvaccinated). Their knowledge was assessed in the third section through several questions about vaccine effectiveness and current guidelines related to vaccination in Saudi Arabia as well as internationally. The fourth section discussed questions related to HCP practices, such as the current practice in their hospitals with respect to vaccine administration and offering the vaccine to HCPs and patients. In the final section, questions about vaccine awareness, such as accessibility to the vaccine, current guidelines, associated risk and symptoms of infection, were discussed (see Additional file [1](#MOESM1){ref-type="media"}).

For validation, the questionnaire was assessed by a pilot study of 10 experienced HCPs with both a clinical and research background to determine if the questions were valid, clear and understandable. The questionnaire was partially modified on the basis of the results obtained, and these modifications were in the English language. The data collected in pilot study was excluded from the final results. The questionnaire was adopted from a published study and is in English language since the study population is HCPs.

Data collection {#Sec4}
---------------

A total of 405 self-administered questionnaires were distributed among the HCPs of hospitals, and the HCPs were recruited using a simple sampling technique. The questionnaire was anonymous. The data collection was completed during October--November, 2016 by four trained Pharm D senior students. The data collectors obtained the complete data in 3 visits. The data collector explained the study and its purpose to each HCP and informed them that participation was voluntary. Accepting and returning a completed questionnaire was taken as consent to participate in the study. During the first visit to the study sites, the questionnaires were distributed to all sampled HCPs who were invited and consented to participate, and the completed questionnaires were collected within 5 days. The data collectors made a second visit to the study site within three days to ensure maximum participation of the sampled HCPs. In addition, the data collectors made a third visit and conducted face-to-face interviews to complete the questionnaires for some HCPs who consented to participate and received the questionnaires but, due to their busy schedule, could not complete the questionnaires.

Power calculation {#Sec5}
-----------------

To calculate the sample size of the study, a 95% confidence level was used, and the absolute error was estimated to be 5%. In addition, a previous study was conducted under similar settings, which found that the influenza vaccination rate of HCPs was approximately 38%. All previous information was used to calculate the sample size for this study, which yielded a required sample size of 364 participants \[[@CR31]--[@CR33]\].

Statistical analysis {#Sec6}
--------------------

The data was entered and analyzed using the Statistical Analysis Software (SAS®) version 9.2. The frequencies of survey items were described by descriptive statistical analysis. The categorical variables were compared by the chi-square test. The dependent variable was the vaccination status (uptake) and it was dichotomous (i.e., vaccinated or unvaccinated). The relationship between the dependent variable (vaccination status) and the independent variables was determined by bivariate analysis such as the chi-square test or independent t-test. Those independent variables that were significantly associated with the dependent variable were entered into the logistic regression to determine the predictors for vaccination status or uptake. The level of statistical significance was set at *P* \< 0.05.

Results {#Sec7}
=======

A total of 364 HCPs responded completely to the study, with a response and completion rate of 90%. A large proportion (61.8%) of participants were female. Regarding profession, the majority (60.4%) of the participants were nurses followed by physicians and pharmacists (14.8 and 12.6%, respectively) as shown in Table [1](#Tab1){ref-type="table"}. Furthermore, most of the participating HCPs (33.8%) were general practitioners. While there was comparable participation between government-run and private institutions, there were slightly more government-run institutions (57.7% vs 43.3%).Table 1Demographics of healthcare professionals CharacteristicCategoryFrequency (%)GenderMale139 (38.2)Female225 (61.8)ProfessionPhysician54 (14.8)Pharmacist46 (12.6)Nurse220 (60.4)Laboratory scientist15 (4.1)Others28 (7.9)SpecialtyGeneral practice123 (33.8)Pediatrics21 (5.8)Family medicine7 (1.9)Internal medicine58 (15.9)Obstetrics & gynecology11 (3.0)Geriatrics2 (0.5)Pharmacy46 (12.6)Other96 (26.4)Place of practiceGovernment-run hospital210 (57.7)Private hospital154 (42.3)

Among respondents, 67.6% of HCPs were vaccinated. Of those, there were no significant differences in the vaccination rate among the various professions (physicians 68%, pharmacists 72% and nurses 69%, *P* = 0.29). With respect to each profession, there was a significant difference between the vaccinated HCPs and unvaccinated HCPs (e.g., vaccinated physicians 68% vs unvaccinated physician 32%, *P* \< 0.0001).

Approximately 7% of participants did not get vaccinated because of fear of sickness, and 7% did not routinely get vaccinated because they believed that they have never had influenza, followed by approximately 5.2% of participants who did not get vaccinated because they follow precautionary procedures (i.e., washing hands and covering their nose and mouth during sneezing) Fig. [1](#Fig1){ref-type="fig"}.Fig. 1Reasons for rejecting routine vaccination

The majority (84.1%) of participants believed that the influenza vaccine is effective in preventing influenza infection, and of these, 94% were physicians, followed by pharmacists (89%) and nurses (83%) (*P* = 0.01). In terms of vaccination uptake, 74% of the HCPs who believed that the vaccine is effective for preventing influenza infection were vaccinated.

Approximately 58.7% of HCPs believed that the Saudi SCIPV guidelines recommend that HCPs should receive the flu shot. Of these HCPs, physicians comprised the highest percentage (65%), followed by nurses (61%) and pharmacists (50%). Nearly 62% of HCPs think the flu vaccine should be administered annually as shown in Table [2](#Tab2){ref-type="table"}.Table 2Knowledge of healthcare professionals QuestionResponseFrequency (%)\**P* valueDo you think the influenza vaccine is effective in preventing the flu?Yes306 (84.1)\< 0.001No58 (15.9)Do you believe that the Saudi Scientific Committee for Influenza and Pneumococcal Vaccination (SCIPV) recommends that health care workers receive the flu shot?Yes213 (58.7)\< 0.001No29 (8.0)I do not know121 (33.3)How often do you think the flu vaccine should be administered?Every 6 months83 (22.8)\< 0.001Every year225 (61.8)Every 5 years19 (5.2)Once in a lifetime37 (10.2)\*Chi square test

The majority of HCPs (80.2%) believed that the influenza vaccine should be part of the medical practice for HCPs (*P* \< 0.001). Furthermore, 90% of physicians believed that the influenza vaccine should be part of medical practice, followed by nurses (81%) and pharmacists (76%), compared to those who did not believe from the same profession. In addition, 72% of the vaccinated HCPs believed that the influenza vaccine should be part of medical practice versus 27% of unvaccinated HCPs, and approximately 42.0% of HCPs believed that flu vaccine reduces the duration of disease. Only 34.9% of the HCPs' medical centers require and offer the influenza vaccine, and approximately 16% do not offer the vaccine. Thirty-five percent of HCPs consider it a protective measure for patients, and 13.5% deem it an exemplary practice for other workers.

Approximately 70% of the HCPs did not attend any training related to the influenza vaccine; however, 65.1% of the HCPs are interested in attending these trainings. A large number of the centers (63.7%) are offering the influenza vaccine to the patients. Nevertheless, only half of the centers have standing orders regarding the influenza vaccine (Table [3](#Tab3){ref-type="table"}).Table 3Practice patterns regarding influenza vaccinationQuestionResponseFrequency (%)\*\**P* valueDo you think administering the influenza vaccine should be part of your medical practice?Yes292 (80.2)\< 0.001No70 (19.2)\*Which statement applies to your practice/center regarding influenza vaccine for office staff?We require and offer the influenza vaccine127 (34.9)0.03We encourage and offer the influenza vaccine157 (43.1)We require, but do not offer, the influenza vaccine14 (3.8)We encourage, but do not offer, the influenza vaccine44 (12.1)None of the above22 (6.0)Have you or your staff participated in any training or continuing education related to the influenza vaccine in the past 12 months?Yes107 (29.4)\< 0.001No257 (70.6)Would you or your staff be interested in participating in training related to the influenza vaccine?Yes237 (65.1)\< 0.001No127 (34.9)Does your practice/center offer the influenza vaccine to your patients?Yes232 (63.7)\< 0.001No39 (10.7)I do not know93 (25.5)Does your practice/center have standing orders regarding the influenza vaccine?Yes186 (51.1)\< 0.001No59 (16.2)I do not know119 (32.7)\* 3 participants did not respond to this question\*\* Chi square test

As for communication to the patients with respect to promotion of the influenza vaccine, approximately 50% of HCPs promote influenza vaccination through a poster or brochure, 15.4% by text reminder, 7.1% by telephone calls, and 5.2% by email reminder (*P* \< 0.001). Furthermore, approximately 36.8% of HCPs promote it during patient visits, and 31.3% of HCPs promote a designated vaccination day (*P* ≤ 0.001). Less than 7% use some other source to promote vaccination. Unfortunately, 8.8% of HCPs are not engaged in promotional activities for the influenza vaccine. Among those who were vaccinated, 55% promoted vaccination through a poster or brochure, followed by 37% during patient visits, 33% during vaccination day and 20% through text reminders.

Approximatly 37% of HCPs believe that availability of the vaccine is a big barrier in the vaccination rate, and also cost/reimbursement issues (38%). Furthermore, vaccine safety concerns of HCPs (58.0%) was the highest contributing barrier of vaccination, as given in Fig. [2](#Fig2){ref-type="fig"}.Fig. 2Barriers with regard to the vaccination rate

Table [4](#Tab4){ref-type="table"} shows that 74.2% of the HCPs believed that influenza is more serious than a "common cold", and 48% of the HCPs do believe that patients can transmit influenza even if they are asymptomatic. Interestingly, approximately 20% of the HCPs who participated in this study thought that HCPs are less susceptible to influenza infection than others.Table 4Level of awareness regarding disease and vaccinationQuestionResponse frequency (%)\**P* value with respect to categoriesCorrectIncorrectNot sureHCPs are less susceptible to influenza infections than other people69 (19.0)275 (75.5)20 (5.5)\< 0.001Influenza is transmitted primarily by coughing and sneezing318 (87.4)19 (5.2)27 (7.4)\< 0.001Influenza is more serious than a "common cold"270 (74.2)48 (13.2)46 (12.6)\< 0.001The signs and symptoms of influenza include fever, headache, sore throat, cough, nasal congestion, and aches and pains326 (89.6)5 (1.4)33 (9.1)\< 0.001HCPs can spread influenza even when they are feeling well220 (60.4)52 (14.3)92 (25.3)\< 0.001People with influenza can transmit the infection only after their symptoms appear125 (34.3)176 (48.4)63 (17.3)\< 0.001Influenza is transmitted primarily by contact with blood and body fluids106 (29.1)187 (51.4)106 (19.5)\< 0.001Influenza vaccination may not work if the vaccine contains the wrong mix of viruses244 (67.0)26 (7.1)94 (25.8)\< 0.001The flu shot contains live viruses that may cause some people to get influenza154 (42.3)125 (34.3)85 (23.4)\< 0.001Influenza vaccination does not work in some persons, even if the vaccine has the right mix of viruses201 (55.2)52 (14.3)111 (30.5)\< 0.001Adults with influenza commonly experience nausea and vomiting or diarrhea184 (50.5)89 (24.5)91 (25.0)\< 0.001Symptoms typically appear 8 to 10 days after a person is exposed to influenza125 (34.3)105 (28.8)134 (36.8)0.163\* Chi square test

Table [5](#Tab5){ref-type="table"} shows the results of the multivariate logistic regression analyses. HCPs' belief that vaccination prevent influenza infection (odds ratio (OR) = 3.93, 95% confidence interval (CI) = 1.97--7.82), their awareness of the guidelines and recommendations from the current advisory committee on immunization practices and the SCIPV (OR = 2. 13, 95% CI = 1.16--3.90) and the presence of standing orders regarding the influenza vaccine (OR = 1.57, 95% CI = 1.01--3.21), were the predictors for HCPs' acceptance of the influenza vaccine.Table 5Logistic regression analysis identifying predictors for receiving the influenza vaccine among the participating healthcare professionalsOdds Ratio (OR)95% confidence interval (CI)Gender Female (reference)\-- Male1.4040.784--2.514Profession (Physician, reference)\-- Pharmacist1.0750.414--2.790 Nurse1.4610.659--3.241Practice site (Private hospital, reference)\-- Governmental hospital1.1700.677--2.023Vaccine is effective in preventing influenza No (reference)\-- Yes3.9341.979--7.820Influenza vaccine should be part of your medical practice No (reference)\-- Yes1.3260.684--2.574Have standing orders regarding the influenza vaccine No (reference) Yes1.5701.017--3.214 I don't know0.9270.455--1.886Aware of ACIP, SCIPV or CDC recommendations No (reference)\-- Yes2.1311.163--3.907

Discussion {#Sec8}
==========

This study investigated the knowledge, attitude, and practice of HCPs working in Saudi hospitals and primary care centers regarding influenza vaccines during the 2016 season. This study had a high response rate (90%), which is similar to other studies performed in the same region \[[@CR31], [@CR34]\].

The current study shows an increase in influenza vaccination of HCPs, at 67.6%, in the 2016 season in the central part of Saudi Arabia. This vaccination rate is considerably higher than previous years. Indeed, the current vaccinate rate (67.6%) represents an approximate 43% increase over the vaccination rate reported among HCPs (38%) in a previous study conducted in similar settings in the 2013 season \[[@CR31]\]. The increase in the vaccination rate in this study compared with that in a previous study done in Saudi Arabia could be due to the adoption of recommendations from the previous study by the ministry of health. Furthermore, our finding is comparable to a Kuwaiti study that reported a similar rate of 67.2% \[[@CR35]\] and appears consistent with trends in a developed setting \[[@CR36]--[@CR38]\]. This study also reveals a higher vaccination rate among HCPs than other similar studies conducted in African (6.5%) and Asian (17.0%) countries \[[@CR39], [@CR40]\].

The high level of acceptance and uptake of influenza vaccination reported by HCPs in Saudi Arabia is an exciting development with a potential positive impact on public health. It is well established that HCPs' attitude and acceptance of and participation in influenza vaccination are consistently correlated to vaccination by patients and the level of public trust in the utilitarian value of vaccination in enhancing public health \[[@CR18], [@CR20], [@CR41]\].

Furthermore, the increase in favorable attitudes of HCPs to routine influenza vaccination suggests highly motivated professionals who appear poised to enhance patients' uptake of influenza vaccination with adequate education that will correctly guide informed vaccination-related decisions. This position is consistent with our finding that showed that a majority of the HCPs actively promote vaccination and educate patients about its associated health benefits during face-to-face interactions and via a variety of media, such as posters, brochures, short reminder messages service via mobile phones and telephone calls. These remarkable vaccine-friendly practices by this sample of HCPs can only strengthen the culture of vaccination and adoption of influenza vaccine specifically among Saudi patients and the public \[[@CR11]\].

The factors underlining our finding that showed the remarkable increase in the HCP use of the influenza vaccine appear multifactorial. We identified regular availability and ease of access to influenza vaccine in about two-thirds of the study sites, and this appeared to be an important contributory factor. Ease of access to influenza vaccines is a potent factor that can enhance acceptance and use especially among HCPs with an intrinsic positive attitude to influenza vaccination and vice-versa. Indeed, limited access to the influenza vaccine was cited by approximately 37% of HCPs as a potential threat to high immunization coverage, and this is consistent with findings of other studies in India and Turkey as well as those in similar settings that have identified difficult access as a key factor underlining low influenza vaccination coverage among HCPs \[[@CR29], [@CR31], [@CR40], [@CR42]--[@CR44]\].

Furthermore, a recent study in Saudi Arabia showed that other contributory factors may also be at play. These include institutional initiatives to more deeply engage HCPs, especially nurses, to champion the uptake of influenza vaccination by HCPs \[[@CR45]\]. This is because studies have consistently shown that the influenza vaccination rate is higher among nurses relative to other HCPs in Saudi Arabia, and this trend is also consistent with our findings \[[@CR45], [@CR46]\].

In contrast to a study from Switzerland, this study indicates that nurses are well-positioned to champion influenza vaccination by other HCPs \[[@CR10]\]. Hence, nurses appeared well-positioned to champion increased influenza vaccination by other HCPs. Perhaps, the larger proportion of nurses, relative to other HCPs, and their more frequent contact with patients increases their risk of exposure to infectious disease such as influenza. Indeed, concerns with perceived increased risk of exposure to infection have been reported as a key motivating factor for high influenza vaccine use among HCPs \[[@CR29], [@CR47], [@CR48]\].

Hence, adopting nurses as "influenza vaccine champions" may be a simple but potentially effective strategy that could boost acceptance and use of the influenza vaccine among HCPs in similar healthcare settings. Furthermore, the progressive shift of organizational policy in some of the health institutions in Saudi Arabia from voluntary to mandatory requirement of the yearly uptake of influenza vaccination for HCPs is also probably contributory. However, this phenomenon was not specifically explored in our study, but it has been established that the institutionalized policy of mandatory rather than voluntary vaccination almost always increased the influenza vaccination rate among HCPs \[[@CR45], [@CR49], [@CR50]\].

Despite the apparent incremental progress in the influenza vaccination rate of HCPs in Saudi Arabia, a considerable amount of work is required to sustain this progress. This is because our study identified some factors that, if not resolved, may increase the risk of vaccine hesitancy and threaten immunization coverage. Although, this was identified in a small proportion of HCPs, especially physicians, it nonetheless deserves serious attention. Similar to a French study, this study also indicates some of the barriers to the vaccination of HCPs \[[@CR51]\]. These factors include absence of past influenza infection, concerns that influenza vaccination may lead to sickness, false sense of protection from influenza infection due to strict adherence to hand-washing and safety concerns with influenza vaccine. These findings are consistent with similar reports from several published studies and can potentially increase vaccine hesitancy among HCPs if left unresolved \[[@CR30], [@CR31], [@CR38], [@CR52]\]. Therefore, there remains a need for a functional institutional framework that regularly monitors HCPs for vaccine-unfriendly attitudes and beliefs and resolves any potential problems that could compromise the integrity of the annual influenza vaccination program.

Our study shows a general positive attitude toward influenza vaccination by the sampled HCPs, as a majority is confident in the efficacy of the influenza vaccine to protect against and reduce the duration of infection and recommends its uptake regularly to patients and other HCPs. This finding is similar to the trends observed in published studies among HCPs with good acceptance and uptake of influenza vaccinations \[[@CR29], [@CR30], [@CR48]\].

Furthermore, our study showed that approximately 70% of HCPs did not attend any specific training related to influenza infection and vaccine in recent years, though they express desire to do so. Published literature in the study area has not truly established a consistent correlation between HCP awareness of relevant updates related to vaccine and vaccination and the actual acceptance and uptake of influenza vaccination because of the complex and multilayered nature of behavioral and organizational factors associated with vaccine hesitancy \[[@CR15], [@CR17], [@CR48]\]. It is nonetheless important to ensure that opportunities are provided to HCPs to regularly update their knowledge of current guidelines and other relevant information related to influenza infection and vaccine.

This study has several strengths and limitations. It was conducted in 8 major government-run and private hospitals and their primary clinics at distinct locations in the cities of Riyadh and Hail, covering both sectors and a relatively large number of hospitals. In addition, face-to-face interviews were conducted by the choice of HCPs and resulted in the participation of professionals from diverse professions. Therefore, this study illustrates vaccination coverage in different professions.

The low representation of physicians and pharmacists is one of the limitations to this study. The use of self-reporting for data gathering may be a possible limitation in the interpretation of the findings presented due to recall bias. However, published studies have established strong concordance between self-reported influenza vaccination status and the documented vaccination status in medical records, and hence this concern is unlikely and may be mitigated \[[@CR53]--[@CR55]\]. Furthermore, the high response and completion rate by the sampled HCPs, which ranks among the highest in recent times in Saudi Arabia, suggests that the findings presented probably provide a more valid snapshot of the HCPs' attitude to and uptake of influenza vaccination in Saudi Arabia. As with most such studies (i.e., surveys), volunteer bias is one limitation that could affect the results of the study.

Implications of the study findings {#Sec9}
----------------------------------

This study showed good vaccination coverage and improved HCP beliefs towards the influenza vaccine and vaccination. The study results might be a useful addition to the framework used to assess the impact of the efforts by the Saudi MOH, especially periodic campaigns, to improve vaccinations in Saudi Arabia. Furthermore, health institutions such as hospitals and centers should make vaccination of HCPs an institutionalized standard medical practice, ensure regular availability of the influenza vaccine and provide relevant training and education to HCPs to ensure a sustained increase in influenza vaccination coverage.

Conclusion {#Sec10}
==========

The acceptance of and participation in influenza vaccination by HCPs in Saudi Arabia appears to have markedly increased in the 2016 season. However, there is still a need for appropriate interventions to sustain and subsequently enhance HCP participation rates and improve their knowledge, especially concerning important information about influenza infection and vaccination. This can be accomplished through continuing education and training programs for all categories of HCPs.
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